Omid Farokhzad
CIK 1586852 · CEO AND CHAIR · last filed 2026-02-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.40M
Companies
3
Total Filings
39
Lifetime Open-Market Net
-$102.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-16 | Cartesian Therapeutics, Inc. (SELB) Delisted | — | — | $0 | EDGAR |
| 2019-06-18 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-29 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +83,333 | $125.0K | EDGAR |
| 2018-12-03 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-19 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-01 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-20 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-27 | Cartesian Therapeutics, Inc. (SELB) Delisted | Exer (M) | +60,000 | $235.1K | EDGAR |
| 2016-06-29 | Cartesian Therapeutics, Inc. (SELB) Delisted | Conv (C) | +22,081 | $0 | EDGAR |
Showing 31–39 of 39
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.